Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

IT

Eli Lilly counts up Sixty8 Capital contribution

Eli Lilly has helped Sixty8 Capital hold a first close for its $20m fund, which the venture capital firm will use to back startups led by members of typically underrepresented communities.


May 12, 2021

Safar Partners attracts $191m

The venture fund, focused on companies out of MIT, Harvard and Rochester, has collected more than $191m on its way to a $325m target.

May 11, 2021

Daily Deal Round Up: May 10, 2021

Legend Holdings' Legend Star unit led a round for optical chip producer Turing Quantum sized above $15m while several Japanese companies also raised money.

May 10, 2021

Lightmatter illuminates $80m series B

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

May 10, 2021

Corporates illuminate Lightmatter in $80m series B

Alphabet, Hewlett Packard Enterprise and Lockheed Martin invested in the photonic computing technology developer’s series B round, increasing its total funding to $113m.

May 10, 2021

Analysis: Solid Power with a $130m recharge

Solid-state battery developer Solid Power secured a $130 series B round co-led by its potential customers from the automotive sector BMW and Ford Motor Company.

May 10, 2021

Daily deal net: May 7, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 7, 2021

Vast Data vaults to $83m series D

Nvidia participated in a round valuing the data storage technology provider, which counts Dell, Siemens and Mellanox as investors, at $3.7bn.

May 7, 2021

Daily Deal Round Up: May 6, 2021

Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.

May 6, 2021

Subsector: healthcare IT and administration

A decade or more after setting up the golden age of corporate venturing units were set up with a focus on life sciences and healthcare, such as US-listed conglomerate Alphabet’s GV (formerly known as Google Ventures) and US-listed drugs company Merck’s Global Health Innovation Fund (GHIF), and the returns have surpassed many expectations.

May 6, 2021

AEye amends reverse merger deal downwards

The corporate-backed lidar technology provider will now be valued at $1.52bn pre-acquisition rather than the $1.9bn figure when the deal was announced in February.

May 6, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here